placed in diagnosis related group (DRG) 469 rather than 470 due to new diagnoses assigned during the patients' hospitalization for surgery.All patients in the hospitalist group were optimized prior to surgery in our preoperative center. An anesthesiologist performed the initial screening, and an internist also evaluated the patients [1]. One may assume that most pertinent diagnoses were documented at this time. Given the decreased length of stay in the hospitalist group, and the fact that the increased cost was attributed to testing rather than intervention, the clinical relevance of these new diagnoses is questionable. However, we did not record the patients' DRG. This would have enabled us to definitively determine if more patients in the hospitalist group were placed into better paying DRG 469.Assuming the hospital did receive increased payment, one must also consider the overall cost to the health care system. Searching for more diagnoses, which do not affect the course of the hospitalization for the purpose of increasing hospital reimbursement, places a financial burden on the payors. This burden will eventually be passed down to the hospitals, physicians, and patients. In conclusion, we still believe that in the patient population studied, the increased number of postoperative diagnoses adds unnecessary cost and may adversely affect physician and hospital rankings, which in the long run will have more of a negative impact than any short-term gain in reimbursement.